ReviewOman medical journal2024
Nutritional Management of Dyslipidemia in Pakistan: A Systematic Review of International Guidelines and Practices.
Review in Oman medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Dyslipidemia and atherosclerotic cardiovascular events are highly prevalent in Pakistan, which could be attributed to a lack of education, poverty, unhealthy dietary habits, and the absence of local guidelines. Our main goal was to develop a comprehensive comparison of the existing international dyslipidemia guidelines, highlighting the different nutritional recommendations proposed by each. A secondary objective was to establish local food sources beneficial for dyslipidemia coexistent with other morbidities. Methods: We conducted a systematic review of three databases Pubmed, Scopus, and International Guidelines Library to acquire guidelines for the management of dyslipidemia. The guidelines fulfilling the criteria of the Clinical Practice Guidelines developed by the Institute of Medicine in 2011 were selected for data extraction and their quality was assessed by the Mini-Checklist (MiChe) tool. Using the Harvard Healthy Eating Plate, a modified MyPlate describing portion of each macronutrient was established. Dietary recommendations for dyslipidemia and other comorbidity conditions were developed based on the review of guidelines and data from randomized control trials. Results: A total of 23 guidelines were selected based on our inclusion criteria. Final guidelines presented dietary patterns beneficial for the management of dyslipidemia, which differed due to the availability and cost-effectiveness of nutritional sources in Pakistan. After developing a modified MyPlate better suited to the dietary intakes of the population of Pakistan, nutritional recommendations for dyslipidemia with other comorbids were developed using local sources suggested by practicing dietitians. Conclusions: Dietary modification is the cornerstone of managing dyslipidemia. Due to Pakistan's unique dietary patterns and the economic condition, a multidisciplinary approach with physicians and dietitians is required to develop easily applicable dietary regimes for dyslipidemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.